Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis-Reference-Cited by-同舟云学术

Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis

Published:2022-10 Issue:10 Volume:32 Page:2279-2288
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Pennisi Grazia,Celsa Ciro,Enea Marco,Vaccaro Marco,Di Marco Vito,Ciccioli Carlo,Infantino Giuseppe,La Mantia Claudia^ORCID,Parisi Stefanie,Vernuccio Federica,Craxì Antonio,Cammà Calogero,Petta Salvatore

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference63 articles.

1. Global epidemiology of non-alcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence and outcomes;Younossi;Hepatology,2016

2. Healthcare resource utilization and costs of nonalcoholic steatohepatitis patients with advanced liver disease in Italy;Petta;Nutr Metabol Cardiovasc Dis,2020

3. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis;Taylor;Gastroenterology,2020

4. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease;Kanwal;Gastroenterology,2018

5. Trends in mortality from extrahepatic complications in patients with chronic liver disease, from 2007 through 2017;Kim;Gastroenterology,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials;Clinics and Research in Hepatology and Gastroenterology;2024-06

2. Efficacy of pharmacologic interventions on magnetic resonance imaging biomarkers in patients with nonalcoholic fatty liver disease: systematic review and network meta‐analysis;Journal of Gastroenterology and Hepatology;2024-04-16

3. NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay;Life;2024-02-18

4. Diagnosis and Management of Lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Systematic Review;2024-02-15

5. Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies;Pharmacological Reviews;2024-01-30